nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—Cytochrome P450 3A4 Inhibitors—Colchicine—primary biliary cirrhosis	0.635	1	CiPCiCtD
Pazopanib—ABCG2—primary biliary cirrhosis	0.154	1	CbGaD
Pazopanib—CYP2C8—Colchicine—primary biliary cirrhosis	0.0141	0.347	CbGbCtD
Pazopanib—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.0113	0.278	CbGbCtD
Pazopanib—ABCB1—Colchicine—primary biliary cirrhosis	0.00955	0.235	CbGbCtD
Pazopanib—CYP3A4—Colchicine—primary biliary cirrhosis	0.00572	0.141	CbGbCtD
Pazopanib—MAP3K9—epithelium—primary biliary cirrhosis	0.00173	0.0585	CbGeAlD
Pazopanib—Rilpivirine—ABCG2—primary biliary cirrhosis	0.00159	1	CrCbGaD
Pazopanib—PDGFRA—gall bladder—primary biliary cirrhosis	0.00112	0.0381	CbGeAlD
Pazopanib—Blood glucose increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00109	0.0157	CcSEcCtD
Pazopanib—Blood glucose increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00109	0.0157	CcSEcCtD
Pazopanib—FGFR3—epithelium—primary biliary cirrhosis	0.00102	0.0346	CbGeAlD
Pazopanib—BMPR1B—epithelium—primary biliary cirrhosis	0.00101	0.0343	CbGeAlD
Pazopanib—MAP3K9—liver—primary biliary cirrhosis	0.00098	0.0332	CbGeAlD
Pazopanib—Hypothyroidism—Colchicine—primary biliary cirrhosis	0.000966	0.0139	CcSEcCtD
Pazopanib—Polyp—Chenodeoxycholic acid—primary biliary cirrhosis	0.000916	0.0132	CcSEcCtD
Pazopanib—Polyp—Ursodeoxycholic acid—primary biliary cirrhosis	0.000916	0.0132	CcSEcCtD
Pazopanib—KIT—gall bladder—primary biliary cirrhosis	0.000898	0.0304	CbGeAlD
Pazopanib—PDGFRB—gall bladder—primary biliary cirrhosis	0.000878	0.0297	CbGeAlD
Pazopanib—PI4KB—smooth muscle tissue—primary biliary cirrhosis	0.000872	0.0295	CbGeAlD
Pazopanib—Cyst—Chenodeoxycholic acid—primary biliary cirrhosis	0.000833	0.012	CcSEcCtD
Pazopanib—Cyst—Ursodeoxycholic acid—primary biliary cirrhosis	0.000833	0.012	CcSEcCtD
Pazopanib—FLT4—epithelium—primary biliary cirrhosis	0.000798	0.027	CbGeAlD
Pazopanib—Thrombosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000787	0.0113	CcSEcCtD
Pazopanib—Thrombosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000787	0.0113	CcSEcCtD
Pazopanib—Menorrhagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000753	0.0108	CcSEcCtD
Pazopanib—Menorrhagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000753	0.0108	CcSEcCtD
Pazopanib—TAOK1—liver—primary biliary cirrhosis	0.000735	0.0249	CbGeAlD
Pazopanib—Skin ulcer—Chenodeoxycholic acid—primary biliary cirrhosis	0.000715	0.0103	CcSEcCtD
Pazopanib—Skin ulcer—Ursodeoxycholic acid—primary biliary cirrhosis	0.000715	0.0103	CcSEcCtD
Pazopanib—FGF1—epithelium—primary biliary cirrhosis	0.000709	0.024	CbGeAlD
Pazopanib—SH2B3—liver—primary biliary cirrhosis	0.000692	0.0234	CbGeAlD
Pazopanib—FGF1—smooth muscle tissue—primary biliary cirrhosis	0.000683	0.0231	CbGeAlD
Pazopanib—Gamma-glutamyltransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000677	0.00975	CcSEcCtD
Pazopanib—Gamma-glutamyltransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000677	0.00975	CcSEcCtD
Pazopanib—FGFR2—epithelium—primary biliary cirrhosis	0.000669	0.0227	CbGeAlD
Pazopanib—Creatinine increased—Colchicine—primary biliary cirrhosis	0.000651	0.00938	CcSEcCtD
Pazopanib—FGFR2—smooth muscle tissue—primary biliary cirrhosis	0.000645	0.0218	CbGeAlD
Pazopanib—FLT1—epithelium—primary biliary cirrhosis	0.00062	0.021	CbGeAlD
Pazopanib—Skin discolouration—Ursodeoxycholic acid—primary biliary cirrhosis	0.000617	0.00888	CcSEcCtD
Pazopanib—Skin discolouration—Chenodeoxycholic acid—primary biliary cirrhosis	0.000617	0.00888	CcSEcCtD
Pazopanib—FLT1—smooth muscle tissue—primary biliary cirrhosis	0.000598	0.0202	CbGeAlD
Pazopanib—Hepatic enzyme increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000589	0.00848	CcSEcCtD
Pazopanib—Blood bilirubin increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000589	0.00848	CcSEcCtD
Pazopanib—Hepatic enzyme increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000589	0.00848	CcSEcCtD
Pazopanib—Blood bilirubin increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000589	0.00848	CcSEcCtD
Pazopanib—STK16—liver—primary biliary cirrhosis	0.000589	0.0199	CbGeAlD
Pazopanib—Creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000585	0.00843	CcSEcCtD
Pazopanib—Creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000585	0.00843	CcSEcCtD
Pazopanib—LYN—liver—primary biliary cirrhosis	0.000583	0.0197	CbGeAlD
Pazopanib—FGFR3—liver—primary biliary cirrhosis	0.00058	0.0196	CbGeAlD
Pazopanib—RIOK2—liver—primary biliary cirrhosis	0.00058	0.0196	CbGeAlD
Pazopanib—Musculoskeletal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000564	0.00812	CcSEcCtD
Pazopanib—Musculoskeletal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000564	0.00812	CcSEcCtD
Pazopanib—PDGFRA—smooth muscle tissue—primary biliary cirrhosis	0.00056	0.019	CbGeAlD
Pazopanib—Melaena—Chenodeoxycholic acid—primary biliary cirrhosis	0.000544	0.00784	CcSEcCtD
Pazopanib—Melaena—Ursodeoxycholic acid—primary biliary cirrhosis	0.000544	0.00784	CcSEcCtD
Pazopanib—KDR—epithelium—primary biliary cirrhosis	0.000524	0.0178	CbGeAlD
Pazopanib—STK36—liver—primary biliary cirrhosis	0.000521	0.0176	CbGeAlD
Pazopanib—Hepatic function abnormal—Colchicine—primary biliary cirrhosis	0.000515	0.00742	CcSEcCtD
Pazopanib—PI4KB—liver—primary biliary cirrhosis	0.000513	0.0174	CbGeAlD
Pazopanib—KDR—smooth muscle tissue—primary biliary cirrhosis	0.000505	0.0171	CbGeAlD
Pazopanib—LIMK2—liver—primary biliary cirrhosis	0.000503	0.017	CbGeAlD
Pazopanib—CSF1R—smooth muscle tissue—primary biliary cirrhosis	0.000493	0.0167	CbGeAlD
Pazopanib—Blood alkaline phosphatase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000465	0.00669	CcSEcCtD
Pazopanib—Blood alkaline phosphatase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000465	0.00669	CcSEcCtD
Pazopanib—KIT—epithelium—primary biliary cirrhosis	0.000465	0.0157	CbGeAlD
Pazopanib—Hepatic function abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000463	0.00666	CcSEcCtD
Pazopanib—Hepatic function abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000463	0.00666	CcSEcCtD
Pazopanib—PDGFRB—epithelium—primary biliary cirrhosis	0.000454	0.0154	CbGeAlD
Pazopanib—FLT4—liver—primary biliary cirrhosis	0.000452	0.0153	CbGeAlD
Pazopanib—Gastrointestinal haemorrhage—Colchicine—primary biliary cirrhosis	0.00045	0.00648	CcSEcCtD
Pazopanib—PIP4K2C—liver—primary biliary cirrhosis	0.00045	0.0152	CbGeAlD
Pazopanib—KIT—smooth muscle tissue—primary biliary cirrhosis	0.000448	0.0152	CbGeAlD
Pazopanib—FGFR1—liver—primary biliary cirrhosis	0.000446	0.0151	CbGeAlD
Pazopanib—Cardiac failure congestive—Ursodeoxycholic acid—primary biliary cirrhosis	0.000446	0.00642	CcSEcCtD
Pazopanib—Cardiac failure congestive—Chenodeoxycholic acid—primary biliary cirrhosis	0.000446	0.00642	CcSEcCtD
Pazopanib—PDGFRB—smooth muscle tissue—primary biliary cirrhosis	0.000437	0.0148	CbGeAlD
Pazopanib—MAP3K2—liver—primary biliary cirrhosis	0.000426	0.0144	CbGeAlD
Pazopanib—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.000422	0.00607	CcSEcCtD
Pazopanib—Dehydration—Colchicine—primary biliary cirrhosis	0.000418	0.00603	CcSEcCtD
Pazopanib—Cardiac failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000414	0.00597	CcSEcCtD
Pazopanib—Cardiac failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000414	0.00597	CcSEcCtD
Pazopanib—Cerebrovascular accident—Chenodeoxycholic acid—primary biliary cirrhosis	0.000413	0.00594	CcSEcCtD
Pazopanib—Cerebrovascular accident—Ursodeoxycholic acid—primary biliary cirrhosis	0.000413	0.00594	CcSEcCtD
Pazopanib—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.000405	0.00584	CcSEcCtD
Pazopanib—Gastrointestinal haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000404	0.00582	CcSEcCtD
Pazopanib—Gastrointestinal haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000404	0.00582	CcSEcCtD
Pazopanib—FGF1—liver—primary biliary cirrhosis	0.000402	0.0136	CbGeAlD
Pazopanib—LCK—liver—primary biliary cirrhosis	0.000399	0.0135	CbGeAlD
Pazopanib—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.000397	0.00572	CcSEcCtD
Pazopanib—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00039	0.00562	CcSEcCtD
Pazopanib—Face oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00039	0.00562	CcSEcCtD
Pazopanib—FGFR2—liver—primary biliary cirrhosis	0.000379	0.0128	CbGeAlD
Pazopanib—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000379	0.00546	CcSEcCtD
Pazopanib—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000379	0.00546	CcSEcCtD
Pazopanib—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.000376	0.00542	CcSEcCtD
Pazopanib—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.000376	0.00542	CcSEcCtD
Pazopanib—Liver function test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000373	0.00538	CcSEcCtD
Pazopanib—Liver function test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000373	0.00538	CcSEcCtD
Pazopanib—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.000369	0.00532	CcSEcCtD
Pazopanib—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.000369	0.00532	CcSEcCtD
Pazopanib—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000365	0.00526	CcSEcCtD
Pazopanib—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000365	0.00526	CcSEcCtD
Pazopanib—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000364	0.00524	CcSEcCtD
Pazopanib—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000364	0.00524	CcSEcCtD
Pazopanib—Neutropenia—Colchicine—primary biliary cirrhosis	0.000364	0.00524	CcSEcCtD
Pazopanib—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000357	0.00514	CcSEcCtD
Pazopanib—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000357	0.00514	CcSEcCtD
Pazopanib—FLT1—liver—primary biliary cirrhosis	0.000352	0.0119	CbGeAlD
Pazopanib—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000343	0.00493	CcSEcCtD
Pazopanib—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000343	0.00493	CcSEcCtD
Pazopanib—Stomatitis—Colchicine—primary biliary cirrhosis	0.000338	0.00487	CcSEcCtD
Pazopanib—STK10—liver—primary biliary cirrhosis	0.000333	0.0113	CbGeAlD
Pazopanib—TAOK3—liver—primary biliary cirrhosis	0.000332	0.0112	CbGeAlD
Pazopanib—Haematuria—Colchicine—primary biliary cirrhosis	0.000331	0.00476	CcSEcCtD
Pazopanib—PDGFRA—liver—primary biliary cirrhosis	0.00033	0.0112	CbGeAlD
Pazopanib—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000319	0.00459	CcSEcCtD
Pazopanib—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000319	0.00459	CcSEcCtD
Pazopanib—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000316	0.00455	CcSEcCtD
Pazopanib—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000316	0.00455	CcSEcCtD
Pazopanib—UGT1A1—liver—primary biliary cirrhosis	0.000314	0.0106	CbGeAlD
Pazopanib—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.000312	0.00449	CcSEcCtD
Pazopanib—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000312	0.00449	CcSEcCtD
Pazopanib—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.000312	0.00449	CcSEcCtD
Pazopanib—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000312	0.00449	CcSEcCtD
Pazopanib—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.00031	0.00446	CcSEcCtD
Pazopanib—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.000307	0.00442	CcSEcCtD
Pazopanib—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.000307	0.00442	CcSEcCtD
Pazopanib—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000305	0.0044	CcSEcCtD
Pazopanib—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000305	0.0044	CcSEcCtD
Pazopanib—Jaundice—Chenodeoxycholic acid—primary biliary cirrhosis	0.000304	0.00437	CcSEcCtD
Pazopanib—Jaundice—Ursodeoxycholic acid—primary biliary cirrhosis	0.000304	0.00437	CcSEcCtD
Pazopanib—KDR—liver—primary biliary cirrhosis	0.000297	0.0101	CbGeAlD
Pazopanib—MAP2K5—liver—primary biliary cirrhosis	0.000297	0.0101	CbGeAlD
Pazopanib—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000297	0.00428	CcSEcCtD
Pazopanib—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000297	0.00428	CcSEcCtD
Pazopanib—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.000295	0.00424	CcSEcCtD
Pazopanib—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.000295	0.00424	CcSEcCtD
Pazopanib—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000294	0.00423	CcSEcCtD
Pazopanib—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000294	0.00423	CcSEcCtD
Pazopanib—Eye disorder—Colchicine—primary biliary cirrhosis	0.000291	0.00419	CcSEcCtD
Pazopanib—CSF1R—liver—primary biliary cirrhosis	0.00029	0.00982	CbGeAlD
Pazopanib—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000281	0.00405	CcSEcCtD
Pazopanib—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000281	0.00405	CcSEcCtD
Pazopanib—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000281	0.00404	CcSEcCtD
Pazopanib—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00028	0.00403	CcSEcCtD
Pazopanib—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00028	0.00403	CcSEcCtD
Pazopanib—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000276	0.00398	CcSEcCtD
Pazopanib—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000276	0.00398	CcSEcCtD
Pazopanib—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000276	0.00397	CcSEcCtD
Pazopanib—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000276	0.00397	CcSEcCtD
Pazopanib—Alopecia—Colchicine—primary biliary cirrhosis	0.000275	0.00396	CcSEcCtD
Pazopanib—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000275	0.00396	CcSEcCtD
Pazopanib—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000275	0.00396	CcSEcCtD
Pazopanib—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000274	0.00395	CcSEcCtD
Pazopanib—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000274	0.00395	CcSEcCtD
Pazopanib—Malnutrition—Colchicine—primary biliary cirrhosis	0.000271	0.0039	CcSEcCtD
Pazopanib—KIT—liver—primary biliary cirrhosis	0.000263	0.00892	CbGeAlD
Pazopanib—SLCO1B1—liver—primary biliary cirrhosis	0.000262	0.00886	CbGeAlD
Pazopanib—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000261	0.00376	CcSEcCtD
Pazopanib—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000261	0.00376	CcSEcCtD
Pazopanib—Muscle spasms—Colchicine—primary biliary cirrhosis	0.000261	0.00375	CcSEcCtD
Pazopanib—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00026	0.00374	CcSEcCtD
Pazopanib—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00026	0.00374	CcSEcCtD
Pazopanib—PDGFRB—liver—primary biliary cirrhosis	0.000257	0.00871	CbGeAlD
Pazopanib—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000254	0.00365	CcSEcCtD
Pazopanib—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000254	0.00365	CcSEcCtD
Pazopanib—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000252	0.00363	CcSEcCtD
Pazopanib—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000252	0.00363	CcSEcCtD
Pazopanib—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.000251	0.00361	CcSEcCtD
Pazopanib—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.000251	0.00361	CcSEcCtD
Pazopanib—Anaemia—Colchicine—primary biliary cirrhosis	0.00025	0.00361	CcSEcCtD
Pazopanib—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000247	0.00356	CcSEcCtD
Pazopanib—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000247	0.00356	CcSEcCtD
Pazopanib—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000243	0.00351	CcSEcCtD
Pazopanib—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000243	0.00351	CcSEcCtD
Pazopanib—Leukopenia—Colchicine—primary biliary cirrhosis	0.000243	0.00349	CcSEcCtD
Pazopanib—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00346	CcSEcCtD
Pazopanib—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00346	CcSEcCtD
Pazopanib—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.000234	0.00337	CcSEcCtD
Pazopanib—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.000234	0.00337	CcSEcCtD
Pazopanib—Myalgia—Colchicine—primary biliary cirrhosis	0.000231	0.00332	CcSEcCtD
Pazopanib—Arthralgia—Colchicine—primary biliary cirrhosis	0.000231	0.00332	CcSEcCtD
Pazopanib—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000225	0.00324	CcSEcCtD
Pazopanib—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000225	0.00324	CcSEcCtD
Pazopanib—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000218	0.00314	CcSEcCtD
Pazopanib—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000218	0.00314	CcSEcCtD
Pazopanib—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000218	0.00314	CcSEcCtD
Pazopanib—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000218	0.00314	CcSEcCtD
Pazopanib—Shock—Colchicine—primary biliary cirrhosis	0.000218	0.00313	CcSEcCtD
Pazopanib—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000217	0.00312	CcSEcCtD
Pazopanib—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000217	0.00312	CcSEcCtD
Pazopanib—Skin disorder—Colchicine—primary biliary cirrhosis	0.000215	0.00309	CcSEcCtD
Pazopanib—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000214	0.00308	CcSEcCtD
Pazopanib—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000214	0.00308	CcSEcCtD
Pazopanib—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000212	0.00306	CcSEcCtD
Pazopanib—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000212	0.00306	CcSEcCtD
Pazopanib—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00021	0.00303	CcSEcCtD
Pazopanib—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00021	0.00303	CcSEcCtD
Pazopanib—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000207	0.00299	CcSEcCtD
Pazopanib—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000207	0.00299	CcSEcCtD
Pazopanib—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000207	0.00299	CcSEcCtD
Pazopanib—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000207	0.00299	CcSEcCtD
Pazopanib—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000207	0.00299	CcSEcCtD
Pazopanib—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000207	0.00299	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000206	0.00297	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000206	0.00297	CcSEcCtD
Pazopanib—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.000203	0.00292	CcSEcCtD
Pazopanib—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.000203	0.00292	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000202	0.0029	CcSEcCtD
Pazopanib—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000199	0.00286	CcSEcCtD
Pazopanib—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000199	0.00286	CcSEcCtD
Pazopanib—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000197	0.00284	CcSEcCtD
Pazopanib—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000197	0.00284	CcSEcCtD
Pazopanib—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000196	0.00282	CcSEcCtD
Pazopanib—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000196	0.00282	CcSEcCtD
Pazopanib—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000195	0.00281	CcSEcCtD
Pazopanib—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000195	0.00281	CcSEcCtD
Pazopanib—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000195	0.0028	CcSEcCtD
Pazopanib—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000195	0.0028	CcSEcCtD
Pazopanib—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000193	0.00278	CcSEcCtD
Pazopanib—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000193	0.00278	CcSEcCtD
Pazopanib—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000192	0.00277	CcSEcCtD
Pazopanib—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000192	0.00277	CcSEcCtD
Pazopanib—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000192	0.00277	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000191	0.00275	CcSEcCtD
Pazopanib—Fatigue—Colchicine—primary biliary cirrhosis	0.000191	0.00275	CcSEcCtD
Pazopanib—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000189	0.00273	CcSEcCtD
Pazopanib—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000189	0.00273	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000181	0.00261	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000181	0.00261	CcSEcCtD
Pazopanib—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000181	0.0026	CcSEcCtD
Pazopanib—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00018	0.00259	CcSEcCtD
Pazopanib—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00018	0.00259	CcSEcCtD
Pazopanib—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000178	0.00257	CcSEcCtD
Pazopanib—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000178	0.00257	CcSEcCtD
Pazopanib—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000177	0.00255	CcSEcCtD
Pazopanib—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000177	0.00255	CcSEcCtD
Pazopanib—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000177	0.00254	CcSEcCtD
Pazopanib—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000177	0.00254	CcSEcCtD
Pazopanib—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000175	0.00252	CcSEcCtD
Pazopanib—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000175	0.00252	CcSEcCtD
Pazopanib—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000175	0.00252	CcSEcCtD
Pazopanib—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000173	0.00249	CcSEcCtD
Pazopanib—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000173	0.00249	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000172	0.00247	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000172	0.00247	CcSEcCtD
Pazopanib—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000171	0.00247	CcSEcCtD
Pazopanib—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000171	0.00247	CcSEcCtD
Pazopanib—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00017	0.00245	CcSEcCtD
Pazopanib—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00017	0.00245	CcSEcCtD
Pazopanib—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000162	0.00234	CcSEcCtD
Pazopanib—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000162	0.00234	CcSEcCtD
Pazopanib—Asthenia—Colchicine—primary biliary cirrhosis	0.000159	0.00229	CcSEcCtD
Pazopanib—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000157	0.00226	CcSEcCtD
Pazopanib—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000157	0.00226	CcSEcCtD
Pazopanib—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000151	0.00218	CcSEcCtD
Pazopanib—CYP2C8—liver—primary biliary cirrhosis	0.000149	0.00504	CbGeAlD
Pazopanib—ABCG2—liver—primary biliary cirrhosis	0.000145	0.0049	CbGeAlD
Pazopanib—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000143	0.00205	CcSEcCtD
Pazopanib—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000143	0.00205	CcSEcCtD
Pazopanib—Vomiting—Colchicine—primary biliary cirrhosis	0.000141	0.00203	CcSEcCtD
Pazopanib—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000141	0.00202	CcSEcCtD
Pazopanib—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000141	0.00202	CcSEcCtD
Pazopanib—Rash—Colchicine—primary biliary cirrhosis	0.000139	0.00201	CcSEcCtD
Pazopanib—Dermatitis—Colchicine—primary biliary cirrhosis	0.000139	0.00201	CcSEcCtD
Pazopanib—CYP1A2—liver—primary biliary cirrhosis	0.000139	0.00471	CbGeAlD
Pazopanib—Headache—Colchicine—primary biliary cirrhosis	0.000139	0.002	CcSEcCtD
Pazopanib—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000136	0.00196	CcSEcCtD
Pazopanib—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000136	0.00196	CcSEcCtD
Pazopanib—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000131	0.00189	CcSEcCtD
Pazopanib—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000131	0.00189	CcSEcCtD
Pazopanib—Nausea—Colchicine—primary biliary cirrhosis	0.000131	0.00189	CcSEcCtD
Pazopanib—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000126	0.00182	CcSEcCtD
Pazopanib—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000126	0.00182	CcSEcCtD
Pazopanib—ABCB1—epithelium—primary biliary cirrhosis	0.000126	0.00426	CbGeAlD
Pazopanib—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000125	0.0018	CcSEcCtD
Pazopanib—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000125	0.0018	CcSEcCtD
Pazopanib—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000125	0.0018	CcSEcCtD
Pazopanib—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000125	0.0018	CcSEcCtD
Pazopanib—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000124	0.00179	CcSEcCtD
Pazopanib—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000124	0.00179	CcSEcCtD
Pazopanib—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000118	0.0017	CcSEcCtD
Pazopanib—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000118	0.0017	CcSEcCtD
Pazopanib—CYP3A4—liver—primary biliary cirrhosis	0.000101	0.00341	CbGeAlD
Pazopanib—CYP2D6—liver—primary biliary cirrhosis	9.91e-05	0.00336	CbGeAlD
Pazopanib—ABCB1—liver—primary biliary cirrhosis	7.13e-05	0.00241	CbGeAlD
Pazopanib—KIT—Adaptive Immune System—NFKB1—primary biliary cirrhosis	5.17e-06	7.32e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—AGT—primary biliary cirrhosis	5.15e-06	7.29e-05	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—MMP9—primary biliary cirrhosis	5.15e-06	7.28e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	5.14e-06	7.27e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CCL5—primary biliary cirrhosis	5.12e-06	7.24e-05	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—NFKB1—primary biliary cirrhosis	5.11e-06	7.23e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—NFKB1—primary biliary cirrhosis	5.1e-06	7.21e-05	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—NFKB1—primary biliary cirrhosis	5.09e-06	7.21e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—HIF1A—primary biliary cirrhosis	5.08e-06	7.19e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—TYK2—primary biliary cirrhosis	5.04e-06	7.14e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—CTGF—primary biliary cirrhosis	5.03e-06	7.11e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—OGDH—primary biliary cirrhosis	5e-06	7.08e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—HIF1A—primary biliary cirrhosis	4.99e-06	7.06e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—GOT2—primary biliary cirrhosis	4.98e-06	7.05e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	4.96e-06	7.02e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—TYK2—primary biliary cirrhosis	4.95e-06	7.01e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	4.95e-06	7e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	4.95e-06	7e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	4.94e-06	6.99e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CXCL10—primary biliary cirrhosis	4.92e-06	6.97e-05	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—NFKB1—primary biliary cirrhosis	4.91e-06	6.95e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—GOT1—primary biliary cirrhosis	4.91e-06	6.94e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—NFKB1—primary biliary cirrhosis	4.9e-06	6.93e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	4.88e-06	6.91e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CD80—primary biliary cirrhosis	4.86e-06	6.87e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CXCL10—primary biliary cirrhosis	4.83e-06	6.84e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—CD80—primary biliary cirrhosis	4.77e-06	6.75e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—HIF1A—primary biliary cirrhosis	4.73e-06	6.7e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—TYK2—primary biliary cirrhosis	4.73e-06	6.69e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—HIF1A—primary biliary cirrhosis	4.72e-06	6.68e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—GOT1—primary biliary cirrhosis	4.69e-06	6.64e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—GGT1—primary biliary cirrhosis	4.69e-06	6.64e-05	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	4.67e-06	6.62e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—CTGF—primary biliary cirrhosis	4.65e-06	6.59e-05	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—NFKB1—primary biliary cirrhosis	4.64e-06	6.57e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.62e-06	6.54e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—NOS2—primary biliary cirrhosis	4.62e-06	6.54e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—GOT2—primary biliary cirrhosis	4.61e-06	6.53e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—AGT—primary biliary cirrhosis	4.61e-06	6.52e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—NFKB1—primary biliary cirrhosis	4.59e-06	6.5e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CXCL10—primary biliary cirrhosis	4.59e-06	6.49e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CXCL10—primary biliary cirrhosis	4.58e-06	6.48e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—TYK2—primary biliary cirrhosis	4.57e-06	6.47e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—CD80—primary biliary cirrhosis	4.56e-06	6.46e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—NOS2—primary biliary cirrhosis	4.54e-06	6.42e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CD80—primary biliary cirrhosis	4.53e-06	6.41e-05	CbGpPWpGaD
Pazopanib—ABCG2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	4.52e-06	6.4e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CD80—primary biliary cirrhosis	4.51e-06	6.39e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	4.51e-06	6.38e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.51e-06	6.38e-05	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—NFKB1—primary biliary cirrhosis	4.5e-06	6.36e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—AGT—primary biliary cirrhosis	4.49e-06	6.35e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MMP3—primary biliary cirrhosis	4.49e-06	6.35e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—CD80—primary biliary cirrhosis	4.48e-06	6.34e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PDHX—primary biliary cirrhosis	4.46e-06	6.31e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—NFKB1—primary biliary cirrhosis	4.41e-06	6.24e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MMP3—primary biliary cirrhosis	4.41e-06	6.24e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—CD80—primary biliary cirrhosis	4.4e-06	6.23e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD40LG—primary biliary cirrhosis	4.39e-06	6.21e-05	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—NFKB1—primary biliary cirrhosis	4.32e-06	6.11e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—NOS2—primary biliary cirrhosis	4.31e-06	6.09e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—GOT1—primary biliary cirrhosis	4.3e-06	6.09e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—GGT1—primary biliary cirrhosis	4.3e-06	6.09e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.3e-06	6.08e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—NOS2—primary biliary cirrhosis	4.3e-06	6.08e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—AGT—primary biliary cirrhosis	4.28e-06	6.06e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—HIF1A—primary biliary cirrhosis	4.25e-06	6.02e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CCL5—primary biliary cirrhosis	4.24e-06	6e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ABCB4—primary biliary cirrhosis	4.19e-06	5.93e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—DLAT—primary biliary cirrhosis	4.19e-06	5.93e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MMP3—primary biliary cirrhosis	4.18e-06	5.92e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—CD80—primary biliary cirrhosis	4.18e-06	5.91e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PPARGC1A—primary biliary cirrhosis	4.18e-06	5.91e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MMP3—primary biliary cirrhosis	4.17e-06	5.91e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—CD80—primary biliary cirrhosis	4.17e-06	5.9e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CCL5—primary biliary cirrhosis	4.16e-06	5.89e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CXCL10—primary biliary cirrhosis	4.12e-06	5.83e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	4.11e-06	5.81e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—TYK2—primary biliary cirrhosis	4.1e-06	5.8e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—CD80—primary biliary cirrhosis	4.08e-06	5.77e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD80—primary biliary cirrhosis	4.07e-06	5.76e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CXCL10—primary biliary cirrhosis	4.04e-06	5.71e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	4.03e-06	5.71e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—TYK2—primary biliary cirrhosis	4.03e-06	5.7e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD80—primary biliary cirrhosis	3.98e-06	5.64e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—GGT1—primary biliary cirrhosis	3.98e-06	5.63e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—GOT1—primary biliary cirrhosis	3.98e-06	5.63e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—CD80—primary biliary cirrhosis	3.98e-06	5.63e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—MMP9—primary biliary cirrhosis	3.97e-06	5.62e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CCL5—primary biliary cirrhosis	3.95e-06	5.59e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CCL5—primary biliary cirrhosis	3.94e-06	5.57e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.93e-06	5.56e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—NOS2—primary biliary cirrhosis	3.87e-06	5.48e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—NFKB1—primary biliary cirrhosis	3.86e-06	5.46e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	3.86e-06	5.46e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	3.86e-06	5.46e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TYK2—primary biliary cirrhosis	3.85e-06	5.45e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	3.85e-06	5.44e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.83e-06	5.42e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PPARGC1A—primary biliary cirrhosis	3.83e-06	5.42e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—TYK2—primary biliary cirrhosis	3.82e-06	5.41e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.82e-06	5.4e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—TYK2—primary biliary cirrhosis	3.81e-06	5.39e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CD80—primary biliary cirrhosis	3.79e-06	5.37e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—TYK2—primary biliary cirrhosis	3.78e-06	5.36e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MMP3—primary biliary cirrhosis	3.76e-06	5.32e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CD80—primary biliary cirrhosis	3.75e-06	5.31e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—TYK2—primary biliary cirrhosis	3.72e-06	5.26e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—NFKB1—primary biliary cirrhosis	3.69e-06	5.22e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MMP3—primary biliary cirrhosis	3.68e-06	5.21e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—NUP210—primary biliary cirrhosis	3.62e-06	5.12e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—HIF1A—primary biliary cirrhosis	3.56e-06	5.03e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CCL5—primary biliary cirrhosis	3.55e-06	5.02e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—AGT—primary biliary cirrhosis	3.54e-06	5.02e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PPARGC1A—primary biliary cirrhosis	3.54e-06	5.01e-05	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—NFKB1—primary biliary cirrhosis	3.54e-06	5.01e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—TYK2—primary biliary cirrhosis	3.53e-06	4.99e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—TYK2—primary biliary cirrhosis	3.52e-06	4.98e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—HIF1A—primary biliary cirrhosis	3.49e-06	4.94e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—AGT—primary biliary cirrhosis	3.48e-06	4.93e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CCL5—primary biliary cirrhosis	3.47e-06	4.92e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TYK2—primary biliary cirrhosis	3.44e-06	4.87e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	3.44e-06	4.87e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.44e-06	4.87e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	3.43e-06	4.86e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—TYK2—primary biliary cirrhosis	3.43e-06	4.86e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—HIF1A—primary biliary cirrhosis	3.41e-06	4.83e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.37e-06	4.76e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ABCG2—primary biliary cirrhosis	3.37e-06	4.76e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—TYK2—primary biliary cirrhosis	3.36e-06	4.76e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TYK2—primary biliary cirrhosis	3.36e-06	4.75e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—HIF1A—primary biliary cirrhosis	3.32e-06	4.69e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CXCL10—primary biliary cirrhosis	3.31e-06	4.68e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—HIF1A—primary biliary cirrhosis	3.31e-06	4.68e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—AGT—primary biliary cirrhosis	3.3e-06	4.67e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—AGT—primary biliary cirrhosis	3.29e-06	4.66e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD80—primary biliary cirrhosis	3.26e-06	4.62e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—AGT—primary biliary cirrhosis	3.25e-06	4.6e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	3.23e-06	4.58e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	3.23e-06	4.58e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TYK2—primary biliary cirrhosis	3.2e-06	4.53e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—NFKB1—primary biliary cirrhosis	3.19e-06	4.52e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—TYK2—primary biliary cirrhosis	3.17e-06	4.49e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	3.15e-06	4.46e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CD80—primary biliary cirrhosis	3.14e-06	4.44e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—NFKB1—primary biliary cirrhosis	3.14e-06	4.44e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—NOS2—primary biliary cirrhosis	3.11e-06	4.4e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CD80—primary biliary cirrhosis	3.08e-06	4.36e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—MMP9—primary biliary cirrhosis	3.03e-06	4.29e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MMP3—primary biliary cirrhosis	3.02e-06	4.27e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CD80—primary biliary cirrhosis	3.01e-06	4.26e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—NFKB1—primary biliary cirrhosis	3e-06	4.25e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—AGT—primary biliary cirrhosis	2.98e-06	4.22e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.98e-06	4.22e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—NFKB1—primary biliary cirrhosis	2.98e-06	4.21e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	2.97e-06	4.21e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—NFKB1—primary biliary cirrhosis	2.97e-06	4.2e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—AGT—primary biliary cirrhosis	2.97e-06	4.2e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	2.95e-06	4.18e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	2.93e-06	4.15e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CD80—primary biliary cirrhosis	2.93e-06	4.14e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CD80—primary biliary cirrhosis	2.92e-06	4.13e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.92e-06	4.13e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—AGT—primary biliary cirrhosis	2.91e-06	4.11e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CTGF—primary biliary cirrhosis	2.89e-06	4.09e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GOT2—primary biliary cirrhosis	2.86e-06	4.05e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCL5—primary biliary cirrhosis	2.85e-06	4.03e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	2.76e-06	3.91e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—AGT—primary biliary cirrhosis	2.76e-06	3.91e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	2.76e-06	3.91e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—TYK2—primary biliary cirrhosis	2.75e-06	3.9e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—MMP9—primary biliary cirrhosis	2.71e-06	3.84e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.68e-06	3.8e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—NFKB1—primary biliary cirrhosis	2.67e-06	3.79e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	2.67e-06	3.78e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TYK2—primary biliary cirrhosis	2.65e-06	3.75e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—MMP9—primary biliary cirrhosis	2.64e-06	3.74e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CD80—primary biliary cirrhosis	2.63e-06	3.72e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—NFKB1—primary biliary cirrhosis	2.62e-06	3.71e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.62e-06	3.7e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TYK2—primary biliary cirrhosis	2.6e-06	3.68e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CD80—primary biliary cirrhosis	2.57e-06	3.64e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—TYK2—primary biliary cirrhosis	2.54e-06	3.6e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—MMP9—primary biliary cirrhosis	2.52e-06	3.57e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NUP210—primary biliary cirrhosis	2.52e-06	3.56e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	2.52e-06	3.56e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—ALB—primary biliary cirrhosis	2.5e-06	3.53e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.5e-06	3.53e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	2.49e-06	3.53e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GGT1—primary biliary cirrhosis	2.47e-06	3.5e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GOT1—primary biliary cirrhosis	2.47e-06	3.5e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TYK2—primary biliary cirrhosis	2.47e-06	3.5e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TYK2—primary biliary cirrhosis	2.46e-06	3.49e-05	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.44e-06	3.46e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.39e-06	3.38e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—AGT—primary biliary cirrhosis	2.38e-06	3.37e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	2.37e-06	3.36e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	2.35e-06	3.33e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ABCG2—primary biliary cirrhosis	2.34e-06	3.31e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—ALB—primary biliary cirrhosis	2.29e-06	3.24e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TYK2—primary biliary cirrhosis	2.22e-06	3.14e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PPARGC1A—primary biliary cirrhosis	2.2e-06	3.11e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TYK2—primary biliary cirrhosis	2.17e-06	3.08e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	2.15e-06	3.05e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	2.15e-06	3.05e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—NFKB1—primary biliary cirrhosis	2.15e-06	3.04e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ALB—primary biliary cirrhosis	2.12e-06	3e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CD80—primary biliary cirrhosis	2.11e-06	2.99e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MMP9—primary biliary cirrhosis	2.09e-06	2.95e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.06e-06	2.92e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	2.05e-06	2.9e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MMP9—primary biliary cirrhosis	2.05e-06	2.9e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	2.03e-06	2.87e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	2.03e-06	2.87e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.03e-06	2.87e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CTGF—primary biliary cirrhosis	2.01e-06	2.84e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GOT2—primary biliary cirrhosis	1.99e-06	2.82e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MMP9—primary biliary cirrhosis	1.95e-06	2.75e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	1.94e-06	2.75e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MMP9—primary biliary cirrhosis	1.94e-06	2.75e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.92e-06	2.72e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.92e-06	2.72e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	1.92e-06	2.71e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	1.81e-06	2.56e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	1.81e-06	2.55e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TYK2—primary biliary cirrhosis	1.78e-06	2.52e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MMP9—primary biliary cirrhosis	1.75e-06	2.47e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.73e-06	2.45e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GOT1—primary biliary cirrhosis	1.72e-06	2.43e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GGT1—primary biliary cirrhosis	1.72e-06	2.43e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—AGT—primary biliary cirrhosis	1.71e-06	2.42e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MMP9—primary biliary cirrhosis	1.71e-06	2.42e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.69e-06	2.4e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	1.55e-06	2.19e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	1.54e-06	2.17e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	1.53e-06	2.16e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—AGT—primary biliary cirrhosis	1.49e-06	2.11e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	1.41e-06	1.99e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MMP9—primary biliary cirrhosis	1.4e-06	1.99e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.39e-06	1.96e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	1.33e-06	1.88e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	1.33e-06	1.88e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ALB—primary biliary cirrhosis	1.31e-06	1.86e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—AGT—primary biliary cirrhosis	1.19e-06	1.69e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	1.18e-06	1.67e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ALB—primary biliary cirrhosis	1.14e-06	1.62e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	1.08e-06	1.53e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	9.19e-07	1.3e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ALB—primary biliary cirrhosis	9.14e-07	1.29e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	7.05e-07	9.98e-06	CbGpPWpGaD
